Industry: Health Care – Biotechnology: Biological Products (No Diagnostic Substances)
Stock Symbol: ARTV – NASDAQ
Animal Usage: Animal Testing
Artiva Biotherapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Supporting Evidence:
The company confirms in corporate disclosures that it utilizes animal subjects for product testing and the development of therapeutic candidates.
“On November 1, 2022, the Company entered into a strategic collaboration agreement with Affimed GmbH, a subsidiary of Affimed N.V. for the clinical development and commercialization of a combination therapy, for any uses in humans or animals, comprising Affimed’s product consisting of an innate cell engager referred to as “AFM13” and the Company’s product containing an NK cell referred to as AB-101.” (Page 22) Read the full document
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.
Company Website: https://www.artivabio.com